FDA Pumps the Brakes on Synthetic Dye Phase-Out

The FDA is quietly slowing its synthetic dye phase-out, according to MarketScale. That deceleration arrives at a politically charged moment: 160 food and agriculture groups are simultaneously lobbying for USMCA renewal.

TLDR

• FDA is pulling back on the pace of its synthetic dye phase-out.
• 160 food and agriculture groups are pressing for USMCA renewal simultaneously.
• The dual pressure signals a crowded regulatory moment for food manufacturers.
• Operators planning reformulation timelines may need to reassess their schedules.
• Trade policy and ingredient policy are colliding in ways that affect supply chains.

FDA’s Synthetic Dye Phase-Out Loses Momentum

The FDA’s synthetic dye phase-out had been gaining traction as a clean-label milestone. Now the agency appears to be easing off the accelerator. For manufacturers already mid-reformulation, that shift creates real planning uncertainty.

Brands that moved early, swapping petroleum-based dyes for fruit and vegetable concentrates, now hold a quiet competitive advantage. Those still waiting for a hard regulatory deadline may find the goalposts have moved again.

The clean-label reformulation wave has never depended solely on FDA mandates. Consumer demand and retailer pressure have consistently outpaced federal timelines.

160 Groups and USMCA: The Trade Angle Operators Can’t Ignore

Separately, 160 food and agriculture groups are pressing for USMCA renewal. That coalition is significant. It represents a broad cross-section of the industry, from growers to processors to distributors.

USMCA renewal directly affects ingredient sourcing costs and cross-border supply chain stability. Operators reliant on Mexican or Canadian inputs are watching this closely. Trade disruption can quickly undercut reformulation economics.

In short, two major policy tracks are running in parallel right now. The synthetic dye phase-out slowdown and the USMCA push are not unrelated; both reflect an industry navigating regulatory and trade uncertainty simultaneously. Manufacturers would be wise to stress-test reformulation budgets against both scenarios before committing to timelines.

Source: MarketScale via Google News. Read the original